Monitoring the effects of BCNU chemotherapy Wafers (Gliadel®) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla

Author： Dyke Jonathan   Sanelli Pina   Voss Henning   Serventi Jennifer   Stieg Philip   Schwartz Theodore   Ballon Douglas   Shungu Dikoma   Pannullo Susan  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.82, Iss.1, 2007-03, pp. : 103-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Magnetic resonance spectroscopic imaging in the era of pseudoprogression and pseudoresponse in glioblastoma patient management

By Shim Hyunsuk   Holder Chad A   Olson Jeffrey J  

CNS Oncology, Vol. 2, Iss. 5, 2013-09 ,pp. : 393-396

Future Medicine

Access to resources Recommend Favorite

Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomas

By Porto Luciana  

Brain Tumor Pathology, Vol. 27, Iss. 2, 2010-10 ,pp. : 65-70

Springer Publishing Company

Access to resources Recommend Favorite

Monitoring the effects of mobile phone use on the brain by proton magnetic resonance spectroscopy

By Khiat A.   Boulanger Y.   Breton G.  

International Journal of Radiation Biology, Vol. 82, Iss. 9, 2006-09 ,pp. : 681-685

Informa Healthcare

Access to resources Recommend Favorite

2D-1H proton magnetic resonance spectroscopic imaging study on brain metabolite alterations in patients with diabetic hypertension

By                  

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4232-4238

Spandidos Publications

Access to resources Recommend Favorite

Metabolic changes in acute cerebral infarction: Findings from proton magnetic resonance spectroscopic imaging

By          

Experimental and Therapeutic Medicine, Vol. 7, Iss. 2, 2014-01 ,pp. : 451-455

Spandidos Publications

Access to resources Recommend Favorite